Literature DB >> 15383021

The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease.

Kumanan Wilson1, Maura N Ricketts.   

Abstract

The precautionary principle has emerged as an important new paradigm influencing decision making in the blood system. The principle has influenced decision making in several nations leading to the institution of policies to protect their blood supplies form variant Creutzfeldt-Jakob disease (vCJD). Increasingly evidence has emerged to support the institution of these policies, which were introduced in advance of clear evidence of risk. These vCJD decisions serve as an example of the successful application of precaution and provide lesions as to how the principle should be applied in future transfusion safety decisions.

Mesh:

Year:  2004        PMID: 15383021     DOI: 10.1111/j.1537-2995.2004.04116.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  A new human genotype prone to variant Creutzfeldt-Jakob disease.

Authors:  Kumanan Wilson; Maura N Ricketts
Journal:  BMJ       Date:  2006-05-20

2.  Problems with precaution: the transfusion medicine experience.

Authors:  Kumanan Wilson; Katherine M Atkinson; Dean A Fergusson; Adalsteinn Brown; Alan Forster; Malia S Q Murphy; Alan T Tinmouth; Jennifer Keelan
Journal:  J Risk Res       Date:  2017-07-29

3.  Trade related infections: farther, faster, quieter.

Authors:  Ann Marie Kimball; Yuzo Arima; Jill R Hodges
Journal:  Global Health       Date:  2005-04-22       Impact factor: 4.185

4.  The use of preliminary scientific evidence in public health: a case study of XMRV.

Authors:  Kumanan Wilson; Katherine Atkinson; Jennifer Keelan
Journal:  PLoS Med       Date:  2014-04-08       Impact factor: 11.069

5.  Variant Creutzfeldt-Jakob disease and the Canadian blood system after the tainted blood tragedy.

Authors:  Kumanan Wilson; Ian Graham; Maura Ricketts; Christopher Dornan; Andreas Laupacis; Paul Hebert
Journal:  Soc Sci Med       Date:  2006-10-02       Impact factor: 4.634

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.